Politiparty
Politiparty

118th Congress Health

S. 3733: Shandra Eisenga Human Cell and Tissue Product Safety Act

Introduced

  1. Introduced (completed)Feb 5, 2024
  2. Passed Senate (not reached)
  3. Passed House (not reached)
  4. To the President (not reached)
  5. Became law (not reached)

Summary

Introduced in Senate, Feb 5, 2024

This bill requires the Department of Health and Human Services (HHS) to educate the public and health care providers about the benefits and risks of transplants that use human cell or tissue products, including the risk of infections.

HHS must develop the educational campaign after taking into consideration information about products that carry the highest risk of transmitting infections to transplant recipients. HHS may award grants to other entities to conduct public awareness initiatives and media campaigns about the risk of infections.

The bill also establishes specific civil penalties for violations of laws regarding the spread of communicable diseases and regulations regarding procedures for human cell or tissue products.

Written by the Congressional Research Service, Library of Congress.

Roll calls

0 votes on this bill

No roll call votes have been held on this bill.

Amendments

0 offered

No amendments were offered to this bill.

Cosponsors

2

Bipartisan support.

Who scored on this bill

6 points earned
  1. 1Gary Peters D-MI SponsorIntroduced, drew cross-party cosponsors2 events+6
See all scorers and every scoring event

Introductions and cosponsorships count toward weekly caps and show no points.

Other bills by Gary Peters

History

  1. Feb 5, 2024Introduced in the Senate by Gary Peters.
Show the full action history (2 actions)
  1. Feb 5, 2024Introduced in Senate
  2. Feb 5, 2024Read twice and referred to the Committee on Health, Education, Labor, and Pensions.